Company: SINT
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010496
Chunk: 45

Company: Sintx Technologies, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 2
Chunk 45
---
-Funded Warrants, the “Warrants”) (the Warrants, together with the Shares and
Warrant Shares (as defined below), the “Securities”) with an exercise price of $3.32 per share. The purchase price per
share of Common Stock and the associated Common Warrant was $3.45 and the purchase price per Pre-Funded Warrant and associated
Common Warrant was $3.4499. The Common Warrants are exercisable immediately and expire five-and one-half years from issuance. The
Pre-Funded Warrants are exercisable immediately and terminate when exercised in full.

On March 26, 2024, we closed a
public offering 142,000 shares of our common stock, (the “March 26 Offering”) at a public offering price of $9.40 per share. The
aggregate proceeds from the March 26 Offering were approximately $1.3 million before deducting placement agent fees
and other estimated offering expenses payable by us.

On April 5, 2024, we closed a public
offering of 358,000 shares of our common stock, (the “April 5 Offering”) at a public offering price of $4.20 per share. The
aggregate proceeds from the April 5 Offering were approximately $1.5 million before deducting placement agent fees
and other offering expenses payable by us.

On February 2, 2024, we closed a public offering of 80,000 units, with each unit consisting of one share of its common stock, or one pre-funded warrant to purchase
one share of its common stock, one Class E Warrant with each warrant entitled to purchase one share of common stock, and one Class F
Warrant with each warrant entitled to purchase one share of common stock. Each unit was sold at a public offering price of $50.00. The
Class E and Class F Warrants were immediately exercisable at a price of $50.00 per share. The Class E Warrants expire five years from
the date of issuance and the Class F Warrants expire eighteen months from the date of issuance. Of the $4.0 million of gross proceeds,
approximately $0.6 million were allocated to common stock and prefunded warrants ($0.5 million net of offering costs) and approximately
$3.4 million were allocated to derivative liabilities (with approximately $0.5 million of cash offering costs and $0.1 million of agent
warrant offering costs recorded as